Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Osteoporosis/chemically induced"'
Publikováno v:
Eyre, T A, Jensen, P, Booth, S & El-Galaly, T C 2022, ' Bone health and glucocorticoid-containing lymphoma therapy-a review of risk factors and preventative measures ', British Journal of Haematology, vol. 198, no. 3, pp. 431-442 . https://doi.org/10.1111/bjh.18104
With survival outcomes ever improving for patients with a wide range of lymphoma histologies, the focus on reducing long-term complications of therapy has increased. Recently published, complimentary population and retrospective series have highlight
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d169994ce1ba8bd861d4a7a9a2c26a91
https://vbn.aau.dk/da/publications/d37406f2-405b-41cd-a410-a52ee1afd182
https://vbn.aau.dk/da/publications/d37406f2-405b-41cd-a410-a52ee1afd182
Publikováno v:
Köhler-Forsberg, O, Rohde, C, Nierenberg, A A & Østergaard, S D 2022, ' Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder ', JAMA Psychiatry, vol. 79, no. 5, pp. 454-463 . https://doi.org/10.1001/jamapsychiatry.2022.0337
JAMA Psychiatry
JAMA Psychiatry
Importance: Osteoporosis, a systemic skeletal disorder associated with substantial morbidity and mortality, may be particularly common among individuals with bipolar disorder. Lithium, a first-line mood-stabilizing treatment for bipolar disorder, may
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc92f95aeeff7216c11f81a962f48011
https://pure.au.dk/portal/da/publications/association-of-lithium-treatment-with-the-risk-of-osteoporosis-in-patients-with-bipolar-disorder(30dd1c89-eb87-492b-9c9c-d0f9a2a5b355).html
https://pure.au.dk/portal/da/publications/association-of-lithium-treatment-with-the-risk-of-osteoporosis-in-patients-with-bipolar-disorder(30dd1c89-eb87-492b-9c9c-d0f9a2a5b355).html
Autor:
Yuki M.F. Andersen, Torben Harsløf, Jesper Hallas, Peter Schwarz, Anton Pottegård, Jacob P. Thyssen, Alexander Egeberg
Publikováno v:
Egeberg, A, Schwarz, P, Harsløf, T, Andersen, Y M F, Pottegård, A, Hallas, J & Thyssen, J P 2021, ' Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures ', JAMA Dermatology, vol. 157, no. 3, pp. 275-282 . https://doi.org/10.1001/jamadermatol.2020.4968
Importance Systemic and inhaled corticosteroids negatively affect bone remodeling and cause osteoporosis and bone fracture when given continuously or in high doses. However, risk of osteoporosis and major osteoporotic fracture (MOF) after application
Autor:
Jens Huober, Anita Giobbie-Hurder, J. Lüthi, G. Berthod, A. Schönenberger, O. Pagani, M. Simcock, Peter Brauchli, C. Genton, Khalil Zaman, S. Aebi, Beat Thürlimann
Publikováno v:
Annals of Oncology, vol. 23, no. 6, pp. 1474-1481
Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448
Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448
BACKGROUND The risk of osteoporosis and fracture influences the selection of adjuvant endocrine therapy. We analyzed bone mineral density (BMD) in Swiss patients of the Breast International Group (BIG) 1-98 trial [treatment arms: A, tamoxifen (T) for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73822c30544d5b00ec3e10c9ff561769
http://doc.rero.ch/record/300587/files/mdr448.pdf
http://doc.rero.ch/record/300587/files/mdr448.pdf
Publikováno v:
Andersen, B N, Johansen, P B & Abrahamsen, B 2016, ' Proton pump inhibitors and osteoporosis ', Current Opinion in Rheumatology, vol. 28, no. 4, pp. 420-425 . https://doi.org/10.1097/BOR.0000000000000291
PURPOSE OF REVIEW: The purpose of the review is to provide an update on recent advances in the evidence based on proton pump inhibitors (PPI) as a possible cause of osteoporosis and osteoporotic fractures. This review focuses, in particular, on new s
Autor:
Pia Rosgaard Jensen, Thomas Levin Andersen, Jens Bollerslev, Ellen-Margrethe Hauge, Jean-Marie Delaissé
Publikováno v:
Jensen, P R, Andersen, T L, Hauge, E-M, Bollerslev, J & Delaissé, J-M 2015, ' A joined role of canopy and reversal cells in bone remodeling-Lessons from glucocorticoid-induced osteoporosis ', Bone, vol. 73, pp. 16-23 . https://doi.org/10.1016/j.bone.2014.12.004
Jensen, P R, Andersen, T L, Hauge, E M, Bollerslev, J & Delaissé, J M 2014, ' A joined role of canopy and reversal cells in bone remodeling-Lessons from glucocorticoid-induced osteoporosis ', Bone, vol. 73, pp. 16-23 . https://doi.org/10.1016/j.bone.2014.12.004
Jensen, P R, Andersen, T L, Hauge, E M, Bollerslev, J & Delaissé, J M 2014, ' A joined role of canopy and reversal cells in bone remodeling-Lessons from glucocorticoid-induced osteoporosis ', Bone, vol. 73, pp. 16-23 . https://doi.org/10.1016/j.bone.2014.12.004
Successful bone remodeling demands that osteoblasts restitute the bone removed by osteoclasts. In human cancellous bone, a pivotal role in this restitution is played by the canopies covering the bone remodeling surfaces, since disruption of canopies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16fa0bd39414a604ea8aa88ff62c4d4b
https://portal.findresearcher.sdu.dk/da/publications/28dd42ff-00b4-41af-8c17-a98721235eee
https://portal.findresearcher.sdu.dk/da/publications/28dd42ff-00b4-41af-8c17-a98721235eee
Autor:
Frambati, L, Weber, Kerstin Maud, Canuto, Alessandra, Miralbell, Raymond, Zilli, Thomas, Pichard, Claude, Joly, Caroline, Voison, N, Santos, J Flores Alves Dos
Publikováno v:
Revue médicale suisse, Vol. 9, No 373 (2013) pp. 369-70,372-3
Androgen deprivation is a therapeutic option for patients with prostate cancer, however with a range of side effects that negatively affects their physical and psychological condition. A multidisciplinary care program, ADAPP ("Androgenic deprivation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::1e58143e4f1d61798d85fafe9fd2d697
https://archive-ouverte.unige.ch/unige:40882
https://archive-ouverte.unige.ch/unige:40882
Publikováno v:
Revue médicale suisse, Vol. 7, No 299 (2011) pp. 1299-304
Selective serotonin reuptake inhibitors (SSRI) represent the first-line treatment of depression. Several studies demonstrate that use of therapeutical doses of SSRI is associated with a decreased bone mineral density (BMD) and an increased risk of fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::e8c1385cfe19b115489a1da0a9f86d56
https://archive-ouverte.unige.ch/unige:32698
https://archive-ouverte.unige.ch/unige:32698
Autor:
Kalef-Ezra, J. A., Glaros, D., Klouvas, G. D., Hatzikonstantinou, I., Karantanas, A. H., Siamopoulos, K. C., Pavlidis, Nicholas
Publikováno v:
British Journal of Radiology
The possibility of increased risk for osteoporosis in breast cancer patients treated with tamoxifen was investigated. 26 patients aged 41-65 years without skeletal metastases were studied. All patients were treated with 20 mg/d tamoxifen for a mean t
Autor:
Blair Egerdie, Teuvo L.J. Tammela, Jiri Heracek, Amy Kupic, Robert G. Feldman, Maciej Szwedowski, Carsten Goessl, Fred Saad, Benjamin Z. Leder, Chunlei Ke, Narciso Hernández Toriz, Matthew R. Smith
Publikováno v:
The New England journal of medicine, vol. 361, no. 8, pp. 745-755
Androgen-deprivation therapy is well-established for treating prostate cancer but is associated with bone loss and an increased risk of fracture. We investigated the effects of denosumab, a fully human monoclonal antibody against receptor activator o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca288857baf84758e9dcd8886e443ff2
https://serval.unil.ch/notice/serval:BIB_CBA3A7DE7FAD
https://serval.unil.ch/notice/serval:BIB_CBA3A7DE7FAD